Angiotensin‐converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build‐up phase
Clinical & Experimental Allergy2014Vol. 44(5), pp. 747–755
Citations Over TimeTop 10% of 2014 papers
Abstract
Study data do not provide evidence of an ACEI-mediated increase of VIT-related SR, supporting the continued use of these valuable and hard-to-replace substances throughout VIT.
Related Papers
- → Do Corticosteroids Prevent Biphasic Anaphylaxis?(2017)119 cited
- → Different clinical features of anaphylaxis according to cause and risk factors for severe reactions(2017)45 cited
- → Advancements in Anaphylaxis Management(2022)6 cited
- → Recognition and treatment of anaphylaxis(2010)7 cited
- → How much we know?: Use Of Adrenaline İn Anaphylaxis(2018)